Journal
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY
Volume 18, Issue 6, Pages 820-833Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacr.2020.12.013
Keywords
Cost-effectiveness; advanced neuroimaging; acute ischemic stroke imaging
Funding
- Siemens Medical Solutions USA, Inc.
- Feinstein Institutes for Medical Research, Northwell Health
- National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health [R56NS114275]
- NINDS
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS114275] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The study found that performing comprehensive-CT at presentation is the most cost-effective initial imaging strategy at comprehensive stroke centers, yielding the highest lifetime quality-adjusted life-years. Although comprehensive-MR also yields high quality-adjusted life-years, it has a higher incremental cost-effectiveness ratio compared to comprehensive-CT. Stepwise-CT, stepwise-hybrid, and stepwise-advanced strategies are not cost-effective compared to comprehensive-CT.
Purpose: National guidelines recommend prompt identification of candidates for acute ischemic stroke (AIS) treatment, requiring timely neuroimaging with CT and/or MRI. CT is often preferred because of its widespread availability and rapid acquisition. Despite higher diagnostic accuracy of MRI, it commonly involves complex workflows that could potentially cause treatment time delays. The purpose of this study was to analyze the impact on outcomes of imaging utilization before treatment decisions at comprehensive stroke centers for patients presenting with suspected AIS in the anterior circulation with last-known-well-to-arrival time 0 to 24 hours. Methods: A decision simulation model based on the American Heart Association's recommendations for AIS care pathways was developed from a health care perspective to compare initial imaging strategies: (1) stepwise-CT: noncontrast CT (NCCT) at the time of presentation, with CT angiography (CTA) +/- CT perfusion (CTP) only in select patients (initial imaging to exclude hemorrhage and extensive ischemia) for mechanical thrombectomy (MT) evaluation; (2) stepwise-hybrid: NCCT at the time of presentation, with MR angiography (MRA) +/- MR perfusion (MRP) only for MT evaluation; (3) stepwise-advanced: NCCT + CTA at presentation, with MR diffusion-weighted imaging (MR DWI) + MRP only for MT evaluation; (4) comprehensive-CT: NCCT + CTA + CTP at the time of presentation; and (5) comprehensive-MR: MR DWI + MRA + MRP at the time of presentation. Model parameters were defined using evidence-based data. Cost-effectiveness and sensitivity analyses were performed. Results: The cost-effectiveness analyses revealed that comprehensive-CT and comprehensive-MR yield the highest lifetime qualityadjusted life-years (QALYs) (4.81 and 4.82, respectively). However, the incremental cost-effectiveness ratio of comprehensive-MR is $233,000/QALY compared with comprehensive-CT. Stepwise-CT, stepwise-hybrid, and stepwise-advanced strategies are dominated, yielding lower QALYs and higher costs compared with comprehensive-CT. Conclusions: Performing comprehensive-CT at presentation is themost cost-effective initial imaging strategy at comprehensive stroke centers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available